Abstract:Background: Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is considered to result from the interaction of environmental factors, including intestinal microbiota, with host immune mechanisms in genetically susceptible individuals. Association studies in human and mice indicate that no single organisms are causal for IBD, but instead reflect a broad dysbiosis, suggesting that distinct organisms sharing similar traits may be operative. Owing to the complexity and low inter-individual overlap of the intestinal microbiota, no biologically and ecologically integrated microbial signature of this dysbiosis has been identified in IBD. Results: We performed a study of endoscopic lavage samples from different anatomical sites in 64 subjects (32 normal (NM), 16 CD and 16 UC patients in remission). The V4 region of the 16S ribosomal RNA gene of 190 total mucosal lavage samples was sequenced on an Illumina HiSeq 2000. The microbial composition of lavage specimens was more similar to mucosal biopsies versus fecal compartment (phylum-level Pearson similarity analysis with published datasets), suggesting that mucosal lavage sampling is a good reflection of mucosal-associated microbiota. Phylogenetic diversity was reduced in IBD patients compared to NM subjects. While expected from prior studies of active disease, this is the first demonstration that such differences persist in clinically quiescent phases of disease. A subset of IBD-enriched microbial communities was identified by PCoA of the unweighted UniFrac distance matrix. Network-based analysis of microbial co-occurrence patterns identified 8 functional microbial communities (FMCs). Only one FMC was related to any of the previously reported fecal enterotypes. Bioinformatic validation with two independent mucosal (biopsy) datasets showed that these FMCs are a significantly preserved characteristic of the mucosal surface ecology. Two FMCs were positively and negatively associated with IBD phenotype, and with ATG16L1 and NOD2 risk alleles. Conclusions: We have introduced mucosal lavage as a new sampling method to study host-microbial interaction, and module analysis to identify integrated mucosal ecology parameters for microbial community structure. Our results demonstrate the feasibility of detecting subtle variation between NM and IBD microbiota using relatively short Illumina reads. The identification of FMCs indicated that the intestinal microbiota can be defined as a set of reproducible microbial communities, and that a subset of these are selectively augmented or depleted in IBD patient samples, and with related disease-associated genotypes. Such disease-associated communities provide a new tool to define disease states as microbial ecologic units, and potentially novel integrated units to monitor deleterious microbial states and for therapeutic targeting.

Metabonomics in Ulcerative Colitis: Diagnostics, Biomarker Identification, and Insight into the Pathophysiology

Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease.

1H NMR-based Spectroscopy Detects Metabolic Alterations in Serum of Patients with Early-Stage Ulcerative Colitis

Plasma Nuclear Magnetic Resonance Metabolomics Discriminates Between High and Low Endoscopic Activity and Predicts Progression in a Prospective Cohort of Patients With Ulcerative Colitis

Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis

P140 Serum Metabolomic Biomarkers Can Identify and Characterize Associated Subtypes and Phenotypes in Inflammatory Bowel Disease

Su1930 Nuclear Nano-Morphology Markers from Rectal Tissue for the Surveillance of Colorectal Cancer in Patients with Ulcerative Colitis

Integrated Bile Acid Profile Analysis for The Non-invasive Staging Diagnosis of Ulcerative Colitis

Integrative transcriptomic and metabonomic molecular profiling of colonic mucosal biopsies indicates a unique molecular phenotype for ulcerative colitis

P324 Urine metabolite profile characterizes clinical activity and disease extent in patients with inflammatory bowel disease

P718 Characterization of microbiota and metabolomic profile in human colonic surgical resections of UC patients

Research progress on variations of endogenous metabolites and intestinal bacteria in ulcerative colitis

[An Analysis of Amino Acid Metabolic Profile and Its Clinical Significance in Ulcerative Colitis].

Current and emerging biomarkers for ulcerative colitis

Systematic review of metabolomic alterations in ulcerative colitis: unveiling key metabolic signatures and pathways

Identification of candidate biomarkers for inflammatory bowel disease using non-targeted serum metabolomics

Identification and validation of coagulation and fibrinolytic-related diagnostic biomarkers for ulcerative colitis by bioinformatics analysis

P107 Comparing the Colonic Tissue Proteome of Active and Inactive Ulcerative Colitis

Raman Spectroscopy in the Diagnosis of Ulcerative Colitis

Integration of transcriptomics and metabolomics identify biomarkers of aberrant lipid metabolism in ulcerative colitis

Systemic responses of mice to dextran sulfate sodium-induced acute ulcerative colitis using 1H NMR spectroscopy.